Pancreatic resections for cystic neoplasms: From the surgeon's presumption to the pathologist's reality

Surgery (United States)

Volumn 152, Issue 3 SUPPL., 2012, Pages

  Salvia, Roberto ^a   Malleo, Giuseppe ^a   Marchegiani, Giovanni ^a   Pennacchio, Silvia ^a   Paiella, Salvatore ^a   Paini, Marina ^a   Pea, Antonio ^a   Butturini, Giovanni ^a   Pederzoli, Paolo ^a   Bassi, Claudio ^a  

^a G B ROSSI UNIVERSITY HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CA 19-9 ANTIGEN;

ADULT; AGED; CANCER SURGERY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; ENDOSCOPIC ECHOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS ADENOCARCINOMA; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; RISK FACTOR; SOLID TUMOR; SURGEON; TERTIARY HEALTH CARE;

EID: 84865207721     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2012.05.019     Document Type: Article

References (24)

1. S. Gaujoux, M.F. Brennan, M. Gonen, M.I. D'Angelica, R. DeMatteo, and Y. Fong Cystic lesions of the pancreas: changes in the presentation and management of 1,424 patients at a single institution over a 15-year time period J Am Coll Surg 212 2011 590 600
2. W.R. Brugge, G.Y. Lauwers, D. Sahani, C. Fernandez-del Castillo, and A.L. Warshaw Cystic neoplasms of the pancreas N Engl J Med 351 2004 1218 1226
3. D.V. Sahani, N.I. Sainani, M.A. Blake, S. Crippa, M. Mino-Kenudson, and C.F. del-Castillo Prospective evaluation of reader performance on MDCT in characterization of cystic pancreatic lesions and prediction of cyst biologic aggressiveness AJR Am J Roentgenol 197 2011 W53 W61
4. C. Procacci, G. Carbognin, S. Accordini, C. Biasiutti, A. Guarise, and F. Lombardo CT features of malignant mucinous cystic tumors of the pancreas Eur Radiol 11 2001 1626 1630
5. C. Correa-Gallego, C.R. Ferrone, S.P. Thayer, J.A. Wargo, A.L. Warshaw, and C. Fernandez-Del Castillo Incidental pancreatic cysts: do we really know what we are watching? Pancreatology 10 2010 144 150
6. G. Balzano, A. Zerbi, G. Capretti, S. Rocchetti, V. Capitanio, and V. Di Carlo Effect of hospital volume on outcome of pancreaticoduodenectomy in Italy Br J Surg 95 2008 357 362
7. F. Bosman, F. Carneiro, R. Hruban, N. Theise, WHO Classification of tumors of the digestive system 4th ed. 2010 IARC Press Lyon, France
8. M. Kosmahl, U. Pauser, K. Peters, B. Sipos, J. Luttges, and B. Kremer Cystic neoplasms of the pancreas and tumor-like lesions with cystic features: a review of 418 cases and a classification proposal Virchows Arch 445 2004 168 178
9. J.F. Tseng, A.L. Warshaw, D.V. Sahani, G.Y. Lauwers, D.W. Rattner, and C. Fernandez-del Castillo Serous cystadenoma of the pancreas: tumor growth rates and recommendations for treatment Ann Surg 242 2005 413 419
10. M. Tanaka, S. Chari, V. Adsay, C. Fernandez-del Castillo, M. Falconi, and M. Shimizu International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas Pancreatology 6 2006 17 32
11. R. Salvia, S. Crippa, M. Falconi, C. Bassi, A. Guarise, and A. Scarpa Branch-duct intraductal papillary mucinous neoplasms of the pancreas: to operate or not to operate? Gut 56 2007 1086 1090
12. R. Salvia, C. Bassi, L. Festa, M. Falconi, S. Crippa, and G. Butturini Clinical and biological behavior of pancreatic solid pseudopapillary tumors: report on 31 consecutive patients J Surg Oncol 95 2007 304 310
13. L. Boninsegna, S. Partelli, M.M. D'Innocenzio, P. Capelli, A. Scarpa, and C. Bassi Pancreatic cystic endocrine tumors: a different morphological entity associated with a less aggressive behavior Neuroendocrinology 92 2010 246 251
14. R. Salvia, S. Crippa, S. Partelli, G. Malleo, G. Marcheggiani, and M. Bacchion Pancreatic cystic tumours: when to resect, when to observe Eur Rev Med Pharmacol Sci 14 2010 395 406
15. C.R. Ferrone, C. Correa-Gallego, A.L. Warshaw, W.R. Brugge, D.G. Forcione, and S.P. Thayer Current trends in pancreatic cystic neoplasms Arch Surg 144 2009 448 454
16. C. Correa-Gallego, A.L. Warshaw, and C. Fernandez-del Castillo Fluid CEA in IPMNs: a useful test or the flip of a coin? Am J Gastroenterol 104 2009 796 797
17. N. Faccioli, S. Crippa, C. Bassi, and M. D'Onofrio Contrast-enhanced ultrasonography of the pancreas Pancreatology 9 2009 560 566
18. M. Claudon, D. Cosgrove, T. Albrecht, L. Bolondi, M. Bosio, and F. Calliada Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) - update 2008 Ultraschall Med 29 2008 28 44
19. M. D'Onofrio, A.J. Megibow, N. Faccioli, R. Malago, P. Capelli, and M. Falconi Comparison of contrast-enhanced sonography and MRI in displaying anatomic features of cystic pancreatic masses AJR Am J Roentgenol 189 2007 1435 1442
20. W.R. Brugge Evaluation of pancreatic cystic lesions with EUS Gastrointest Endosc 59 2004 698 707
21. S. Cizginer, B. Turner, A.R. Bilge, C. Karaca, M.B. Pitman, and W.R. Brugge Cyst fluid carcinoembryonic antigen is an accurate diagnostic marker of pancreatic mucinous cysts Pancreas 40 2011 1024 1028
22. W.R. Brugge, K. Lewandrowski, E. Lee-Lewandrowski, B.A. Centeno, T. Szydlo, and S. Regan Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study Gastroenterology 126 2004 1330 1336
23. C. Bassi, R. Salvia, A.A. Gumbs, G. Butturini, M. Falconi, and P. Pederzoli The value of standard serum tumor markers in differentiating mucinous from serous cystic tumors of the pancreas: CEA, Ca 19-9, Ca 125, Ca 15-3 Langenbecks Arch Surg 387 2002 281 285
24. S. Fritz, T. Hackert, U. Hinz, W. Hartwig, M.W. Buchler, and J. Werner Role of serum carbohydrate antigen 19-9 and carcinoembryonic antigen in distinguishing between benign and invasive intraductal papillary mucinous neoplasm of the pancreas Br J Surg 98 2011 104 110